サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564069

心肺自動輸血システムの世界市場

Cardiopulmonary Autotransfusion Systems

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
心肺自動輸血システムの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心肺自動輸血システムの世界市場は2030年までに7億5,960万米ドルに達する見込み

2023年に6億5,380万米ドルと推定される心肺自動輸血システムの世界市場は、2030年には7億5,960万米ドルに達し、分析期間2023-2030年のCAGRは2.2%で成長すると予測されます。本レポートで分析したセグメントの1つであるオンポンプ輸血デバイスは、CAGR 2.4％を記録し、分析期間終了までに5億2,380万米ドルに達すると予測されます。オフポンプ輸血装置セグメントの成長率は、分析期間中CAGR 1.7%と推定されます。

米国市場は1億7,590万米ドルと推定、中国はCAGR1.7％で成長予測

米国の心肺自動輸血システム市場は、2023年に1億7,590万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを1.7%として、2030年までに1億1,800万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と1.4%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界の心肺自動輸血システム市場- 主要動向と促進要因のまとめ

心肺自動輸血システムは外科手術における血液管理にどのような革命をもたらしているのか？

心肺自動輸血システムは、手術中に患者が自分の血液を回収して再利用できるようにすることで、現代の外科手術において重要な役割を果たしています。このようなシステムは、特に心臓手術や外傷手術など、大量の血液を失うことが多い手術において必要不可欠です。従来、輸血はドナー血液に頼ってきたが、この方法には感染症、免疫反応、血液不足などのリスクが伴う。自己輸血システムは、外科手術中に患者自身の血液を採取、ろ過、再輸血することで、これらの問題を軽減します。これにより、ドナー血液の必要性が減少するだけでなく、輸血反応に関連するリスクも減少します。さらに、これらのシステムは、患者がより新鮮で適合性の高い血液を受け取ることを保証し、回復時間を改善し、術後合併症の可能性を減少させる。出血量を効率的に管理することが最も重要である心肺手術において、自動輸血システムは、患者の安定を維持し、ヘルスケアシステムにおけるドナー血液の全体的な需要を減らすために不可欠なものとなっています。

技術はどのように心肺自動輸血システムを向上させたか？

技術の進歩により、心肺自動輸血システムの効率性と信頼性が大幅に向上し、術中の出血管理により効果的になりました。最新の自動輸血装置は、より質の高い再輸血を確実にする高度な濾過・分離技術を備えています。これらのシステムは、赤血球を脂肪、骨片、血栓などの汚染物質から効果的に分離することができ、濾過された清浄な血液のみを患者に戻すことができます。さらに、新しいシステムは、よりコンパクトで使いやすくなっており、セットアップが早く、手術ワークフローへの統合が容易になっています。これらの装置の可搬性は、大型の据置型装置を必要とせず、主要な心臓手術から外傷センターまで、様々な環境で使用できることを意味します。さらに、自動処理システムの導入により、必要な手作業が減り、ヒューマンエラーの可能性が最小限になり、自動輸血プロセスの安全性と信頼性が向上しました。最新のシステムの多くは、リアルタイムのモニタリングとデータ収集機能も備えており、これにより手術チームは手技を通して血液量と血液の質を追跡することができ、患者の転帰を最適なものにすることができます。これらの技術革新は、複雑な手術中に安全で効率的な血液管理を提供する自動輸血システムの能力を大幅に向上させています。

心肺自動輸血システム市場を形成している動向は？

いくつかの主な動向が心肺自動輸血システム市場の成長と開拓に影響を及ぼしており、ヘルスケアプラクティスと手術技術の幅広いシフトを反映しています。大きな動向の一つは、患者の安全性と同種輸血に関連する合併症の減少がますます重視されるようになっていることです。感染症や免疫反応などドナー輸血に関連するリスクに対する認識が高まるにつれ、より安全な代替手段として自動輸血システムを採用するヘルスケアプロバイダーが増えています。さらに、ドナー血液の供給不足と、血液の保存と輸血に関連する高コストが原因で、外科的環境における血液保存技術に対する需要が高まっています。低侵襲手術へのシフトも市場に影響を与えています。これらの手術は侵襲性は低いもの、出血のリスクがあるため、依然として効率的な血液管理システムが必要だからです。この動向は、さまざまな手術環境に適応可能な、より小型で持ち運び可能な自動輸血装置の開発につながっています。さらに、世界中のヘルスケアシステムが医療費削減をますます重要視する中、自動輸血システムは費用対効果の高いソリューションとして支持を集めています。高価なドナー血液の必要性を減らし、術後の合併症を最小限に抑えることで、これらのシステムは、患者の転帰を改善しながら、病院がより効率的にリソースを管理するのに役立ちます。

心肺自動輸血システム市場の成長を促進する主な要因は？

心肺自動輸血システム市場の成長は、技術の進歩、患者の安全に対する意識の高まり、効率的な血液管理ソリューションに対する需要の高まりが組み合わさることによってもたらされます。主な促進要因の一つは、感染症、アレルギー反応、免疫抑制などのリスクを伴う可能性のある同種輸血の安全性に対する懸念の高まりです。ヘルスケアプロバイダーが患者の安全を優先するにつれ、自動輸血システムの採用が増加しており、こうしたリスクを最小限に抑える安全な代替手段を提供しています。もう一つの重要な推進力は、特に血液供給インフラが限られている地域における、ドナー血液のコスト上昇と不足です。自己輸血システムは、患者自身の血液を再利用することで費用対効果の高いソリューションを提供し、ドナー血液への依存を減らし、全体的なヘルスケアコストを削減します。技術の進歩も市場拡大に大きな役割を果たしています。最新の自己血輸血システムは、より効率的で使い勝手がよく、より質の高い再輸血が可能であるため、複雑な手術、特に心臓、整形外科、外傷の症例で好んで使用されます。低侵襲手術の人気の高まりにより、さまざまな手術環境にシームレスに統合できるコンパクトでポータブルな自動輸血システムの需要がさらに高まっています。さらに、ヘルスケアプロバイダーは、リソース管理を改善するために血液保存戦略にますます重点を置くようになっており、自動輸血システムはこの点で効果的なツールとみなされています。さらに、規制機関やヘルスケア組織は、自動輸血を含む血液管理プロトコルを推進しており、病院や手術センター全体でこれらのシステムの採用をさらに促進しています。こうした複合的な要因が、今後数年間も心肺自動輸血システム市場の成長を促進し続けると予想されます。

調査対象企業の例（注目の12社）

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation-Terumo Interventional Systems

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10901

Global Cardiopulmonary Autotransfusion Systems Market to Reach US$759.6 Million by 2030

The global market for Cardiopulmonary Autotransfusion Systems estimated at US$653.8 Million in the year 2023, is expected to reach US$759.6 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$175.9 Million While China is Forecast to Grow at 1.7% CAGR

The Cardiopulmonary Autotransfusion Systems market in the U.S. is estimated at US$175.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$118.0 Million by the year 2030 trailing a CAGR of 1.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Cardiopulmonary Autotransfusion Systems Market - Key Trends and Drivers Summarized

How Are Cardiopulmonary Autotransfusion Systems Revolutionizing Blood Management in Surgery?

Cardiopulmonary autotransfusion systems play a crucial role in modern surgical procedures by allowing patients to recover and reuse their own blood during surgery. These systems are particularly essential in cardiac and trauma surgeries, where significant blood loss is common. Traditionally, blood transfusions have relied on donor blood, but this approach carries risks such as infections, immune reactions, and blood shortages. Autotransfusion systems mitigate these issues by collecting, filtering, and reinfusing the patient’s own blood during the surgical procedure. This not only reduces the need for donor blood but also decreases the risks associated with transfusion reactions. Additionally, these systems ensure that patients receive fresher and more compatible blood, improving recovery times and reducing the likelihood of postoperative complications. In the context of cardiopulmonary surgeries, where managing blood loss efficiently is paramount, autotransfusion systems have become indispensable in maintaining patient stability and reducing the overall demand for donor blood in the healthcare system.

How Has Technology Improved Cardiopulmonary Autotransfusion Systems?

Technological advancements have significantly enhanced the efficiency and reliability of cardiopulmonary autotransfusion systems, making them more effective in managing intraoperative blood loss. Modern autotransfusion devices are now equipped with advanced filtration and separation technologies that ensure higher-quality blood reinfusion. These systems can effectively separate red blood cells from contaminants like fat, bone fragments, and clots, ensuring that only clean, filtered blood is returned to the patient. Additionally, newer systems are more compact and user-friendly, allowing for faster setup and easier integration into surgical workflows. The portability of these devices means they can be used in a variety of settings, from major cardiac surgeries to trauma centers, without the need for large, stationary machines. Furthermore, the introduction of automated processing systems has reduced the manual intervention required, minimizing the chance of human error and improving the safety and reliability of the autotransfusion process. Many of the latest systems also feature real-time monitoring and data collection capabilities, which allow surgical teams to track blood volume and quality throughout the procedure, ensuring optimal patient outcomes. These technological innovations have greatly improved the ability of autotransfusion systems to provide safe, efficient blood management during complex surgeries.

What Trends Are Shaping the Cardiopulmonary Autotransfusion Systems Market?

Several key trends are influencing the growth and development of the cardiopulmonary autotransfusion systems market, reflecting broader shifts in healthcare practices and surgical technologies. One major trend is the increasing emphasis on patient safety and the reduction of complications related to allogeneic blood transfusions. As awareness of the risks associated with donor blood transfusions, such as infections and immune reactions, grows, more healthcare providers are adopting autotransfusion systems as a safer alternative. Additionally, there is a rising demand for blood conservation techniques in surgical settings, driven by shortages in donor blood supplies and the high costs associated with blood storage and transfusion. The shift towards minimally invasive surgeries is also impacting the market, as these procedures, although less invasive, still require efficient blood management systems due to the risk of bleeding. This trend has led to the development of smaller, more portable autotransfusion devices that are adaptable to a range of surgical environments. Moreover, as healthcare systems worldwide place increasing importance on reducing healthcare costs, autotransfusion systems are gaining traction as a cost-effective solution. By reducing the need for expensive donor blood and minimizing postoperative complications, these systems help hospitals manage resources more efficiently while improving patient outcomes.

What Are the Major Factors Driving Growth of the Cardiopulmonary Autotransfusion Systems Market?

The growth in the cardiopulmonary autotransfusion systems market is driven by a combination of technological advancements, increased awareness of patient safety, and the rising demand for efficient blood management solutions. One of the primary drivers is the growing concern over the safety of allogeneic blood transfusions, which can carry risks such as infections, allergic reactions, and immune suppression. As healthcare providers prioritize patient safety, the adoption of autotransfusion systems is increasing, offering a safer alternative that minimizes these risks. Another significant driver is the rising cost and shortage of donor blood, particularly in regions with limited blood supply infrastructure. Autotransfusion systems provide a cost-effective solution by recycling the patient’s own blood, reducing the dependency on donor blood and lowering overall healthcare costs. Advancements in technology have also played a major role in expanding the market. Modern autotransfusion systems are more efficient, user-friendly, and capable of delivering higher-quality blood reinfusion, making them a preferred choice in complex surgeries, especially in cardiac, orthopedic, and trauma cases. The growing popularity of minimally invasive surgeries has further increased the demand for compact, portable autotransfusion systems that can be seamlessly integrated into different surgical environments. Additionally, healthcare providers are increasingly focused on blood conservation strategies to improve resource management, and autotransfusion systems are seen as an effective tool in this regard. Moreover, regulatory bodies and healthcare organizations are promoting blood management protocols that include autotransfusion, further driving the adoption of these systems across hospitals and surgical centers. These combined factors are expected to continue fueling the growth of the cardiopulmonary autotransfusion systems market in the coming years.

Select Competitors (Total 12 Featured) -

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation -Terumo Interventional Systems

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiopulmonary Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Minimally Invasive Surgery Propel Growth of Cardiopulmonary Autotransfusion Systems
    • Aging Population and Increased Cardiovascular Procedures Spur Demand for Autotransfusion Technologies
    • Rising Concerns over Blood Safety and Infection Risks Strengthen the Business Case for Autotransfusion Systems
    • Increased Adoption of Enhanced Filtration Technologies Drives Penetration of Next-Generation Autotransfusion Systems
    • Focus on Blood Conservation in Surgical Procedures Propels Adoption of Autotransfusion Devices
    • Integration of Advanced Monitoring and AI in Autotransfusion Systems Drives Technological Innovation
    • Growing Popularity of Outpatient and Ambulatory Surgical Centers Expands Opportunities for Portable Autotransfusion Systems
    • Surge in Complex Cardiovascular Surgeries Generates Demand for High-Capacity Autotransfusion Devices
    • Here's How Remote Monitoring Capabilities in Autotransfusion Systems Are Transforming Post-Surgical Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiopulmonary Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for On-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Off-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION